New England Research & Management, Inc. Bristol Myers Squibb CO Transaction History
New England Research & Management, Inc.
- $197 Million
- Q4 2024
A detailed history of New England Research & Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New England Research & Management, Inc. holds 26,089 shares of BMY stock, worth $1.48 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
26,089
Previous 53,838
51.54%
Holding current value
$1.48 Million
Previous $2.79 Million
47.02%
% of portfolio
0.75%
Previous 1.31%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,639Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.7 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.02 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.28 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.43 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.43 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...